Testing a lab test to diagnose eye lymphoma from fluid
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial checks how well a molecular (DNA/RNA) lab test can diagnose vitreo-retinal lymphoma, using eye fluid collected during a medically needed procedure. If you have signs doctors suspect this condition, the test may help confirm the diagnosis more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- Your eye doctor suspects vitreo-retinal lymphoma and recommends a diagnostic vitrectomy (eye fluid removal)
- You can sign written informed consent to join the study
- You have not had lymphoma chemotherapy within the last 3 months
- You have not used steroid/cortisone within the last 2 weeks before the vitrectomy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a specific lab marker (sCD160) in blood and eye fluids to see how it relates to poor blood flow in the retina. You may be asked for samples taken during eye surgery to help doctors understand the disease better.
This trial screens people with certain eye inflammation (uveitis) to see if they might have a specific rare lymphoma linked to immune cells. It may help doctors identify the right diagnosis and understand which patients need closer monitoring.
This study collects retina fluid samples from people getting treatment for a vitreoretinal disease. It aims to find better ways to understand and manage these conditions.
This trial tests a treatment for primary vitreoretinal lymphoma, a rare eye cancer. It aims to see if the drug methotrexate can help patients with this condition.
This trial tests a new medicine, RRG001, given after vitrectomy surgery for severe diabetic eye disease. It aims to see if the drug is safe and helps prevent vision loss.
This study looks at the chemicals in the fluid inside your eye (vitreous) using a special scan. It aims to find patterns that might help doctors understand certain eye diseases better.
Hear when a new Vitreoretinal Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.